Follicular lymphoma in staging bone marrow specimens: correlation of histologic findings with the results of flow cytometry immunophenotypic analysis.

CONTEXT Bone marrow (BM) examination is part of the staging workup of lymphoma patients. Few studies have compared BM histologic findings with results of flow cytometric immunophenotyping analysis in follicular lymphoma (FL) patients. OBJECTIVE To correlate histologic findings with immunophenotypic data in staging BM biopsy and aspiration specimens of FL patients. DESIGN Bone marrow biopsy specimens of untreated FL patients were reviewed. Histologic findings were correlated with 3-color flow cytometric immunophenotyping results on corresponding BM aspirates. RESULTS Bone marrow biopsy specimens (with or without aspirates) of 114 patients with histologic evidence of FL in BM were reviewed. There were 76 bilateral and 38 unilateral biopsies performed, resulting in 190 specimens: 187 involved by FL and 3 negative (in patients with a positive contralateral specimen). The extent of BM involvement was < 5% in 32 (17.1%), > or = 5% and < or = 25% in 102 (54.6%), > 25% and < or = 50% in 27 (14.4%), and > 50% in 26 (13.9%) specimens. The pattern of involvement was purely paratrabecular in 81 (43.3%), mixed in 80 (42.8%), and purely nonparatrabecular in 26 (13.9%). Immunophenotyping was only performed unilaterally, on BM aspirates of 92 patients, and was positive for a monoclonal B-cell population in 53 (57.6%) patients. Immunophenotyping was more often negative when biopsy specimens showed FL with a purely paratrabecular pattern. For comparison, we assessed 163 FL patients without histologic evidence of FL in BM also analyzed by flow cytometric immunophenotyping. A monoclonal B-cell population was identified in 5 patients (3%). CONCLUSIONS Our data suggest that 3-color flow cytometric immunophenotyping adds little information to the evaluation of staging BM specimens of FL patients.

[1]  I. Magrath,et al.  Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. , 2006, Medical and pediatric oncology.

[2]  L. Medeiros,et al.  Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. , 2005, American journal of clinical pathology.

[3]  P. Zinzani Lymphoma: diagnosis, staging, natural history, and treatment strategies. , 2005, Seminars in oncology.

[4]  L. Xerri,et al.  Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d‘Etude des Lymphomes Folliculaires , 2004, British journal of haematology.

[5]  L. Medeiros,et al.  CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype. , 2003, Archives of pathology & laboratory medicine.

[6]  E. Torlakovic,et al.  Follicular pattern of bone marrow involvement by follicular lymphoma. , 2002, American journal of clinical pathology.

[7]  L. Medeiros,et al.  The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B‐cell tumours , 2002, British journal of haematology.

[8]  Y. Kanda,et al.  The diagnostic value of kappa/lambda ratios determined by flow cytometric analysis of biopsy specimens in B-cell lymphoma. , 2002, Clinical and laboratory haematology.

[9]  B. Bain Bone marrow trephine biopsy. , 2001, Journal of clinical pathology.

[10]  J. Luider,et al.  Bone marrow staging of patients with non‐Hodgkin lymphoma by flow cytometry , 2000, Cancer.

[11]  E. Smeland,et al.  Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction. , 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[12]  T. Habermann,et al.  Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. , 1999, Blood.

[13]  J. Armitage,et al.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Loken,et al.  Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias , 1998, Leukemia.

[15]  G. Bennett,et al.  Flow‐cytometric algorithm on fine‐needle aspirates for the clinical workup of patients with lymphadenopathy , 1998, Diagnostic cytopathology.

[16]  C. Dunphy Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms. , 1998, American journal of clinical pathology.

[17]  M. Naughton,et al.  Bone marrow staging in patients with non‐hodgkin's lymphoma , 1998, Cancer.

[18]  A. Islam Manual of Bone Marrow Examination , 1997 .

[19]  M. Stetler-Stevenson,et al.  Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia. , 1996, Cytometry.

[20]  H. Frierson,et al.  Quantitative criteria for clonality in the diagnosis of B-cell non-Hodgkin's lymphoma by flow cytometry. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[21]  K. McNally,et al.  Audit of bone marrow trephines. , 1992, Journal of clinical pathology.

[22]  T. Habermann,et al.  Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method. , 1990, American journal of clinical pathology.

[23]  M. Wolf,et al.  Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. , 1990, Journal of clinical pathology.

[24]  K. Foucar,et al.  Bone marrow and blood involvement by lymphoma in relationship to the lukes—collins classification , 1982, Cancer.

[25]  F. Mandelli,et al.  Involvement of the Bone Marrow by Non-Hodgkin's Lymphomas: Incidence, Histology and Pathologic Correlations , 1981, Tumori.

[26]  R. Brynes,et al.  Bone marrow aspiration and trephine biopsy. An approach to a thorough study. , 1978, American journal of clinical pathology.

[27]  C. Bloomfield,et al.  Nodular lymphoma: Bone marrow and blood manifestations , 1975, Cancer.

[28]  C. Bloomfield,et al.  Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. , 1975, Annals of internal medicine.

[29]  C. Bloomfield,et al.  Incidence, cytology, and histopathology of non‐Hodgkin's lymphomas in the bone marrow , 1974, Cancer.

[30]  S. Kroft,et al.  Comparative analysis of light chain expression in germinal center cells and mantle cells of reactive lymphoid tissues. A four-color flow cytometric study. , 2003, American journal of clinical pathology.

[31]  H. Yamase,et al.  The role of flow cytometry in the diagnosis of lymphoma: a critical analysis. , 1994, Annals of clinical and laboratory science.

[32]  K. Voelkerding,et al.  Combined utility of gene rearrangement analysis and flow cytometry in the diagnosis of lymphoproliferative disease in the bone marrow. , 1990, Hematologic pathology.

[33]  S. Gregory,et al.  Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look. , 1989, Hematologic pathology.

[34]  J. Parker,et al.  Limitations of numerical ratios for defining monoclonality of immunoglobulin light chains in B-cell lymphomas. , 1985, Diagnostic immunology.